Torti Frank bought ROIV

February 23, 2026 · Form 4 insider transaction

Torti Frank bought 587,390 shares of Roivant Sciences Ltd. at $3.85 per share, a transaction worth $2.26M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.